Cargando…
Clinical course and visual outcome in patients with diabetes mellitus and uveitis
PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651352/ https://www.ncbi.nlm.nih.gov/pubmed/23628425 http://dx.doi.org/10.1186/1756-0500-6-167 |
_version_ | 1782269211721072640 |
---|---|
author | Oswal, Kadambari S Sivaraj, Ramesh R Murray, Philip I Stavrou, Panagiota |
author_facet | Oswal, Kadambari S Sivaraj, Ramesh R Murray, Philip I Stavrou, Panagiota |
author_sort | Oswal, Kadambari S |
collection | PubMed |
description | PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had Type 2 DM and one had Type 1 DM. Mean age of onset of DM was 49 years and uveitis 55 years. The uveitis was bilateral in 22 (61%) patients. There were 19 patients with anterior uveitis, 12 with panuveitis and 5 with intermediate uveitis. Mean follow up was 4.4 years (range 1-18). Mean number of uveitis recurrences was 3 (range 1-7). Causes of vision of 6/18 or worse appeared related to the uveitis in 9 eyes and diabetes in 4 eyes. Cataract occurred in 22 eyes, glaucoma in 17 eyes, and cystoid macular oedema in 10 eyes. Diabetic retinopathy was detected in 38 (65.5%) eyes (29 non-proliferative including 6 with clinically significant macular oedema, and 9 proliferative). Progression of diabetic retinopathy to proliferative stage occurred in 7 eyes of 4 patients over a mean duration of 4.4 years. In 10 patients with active uveitis the mean HbA1c was 80 mmol/mol [9.5%], (range 49-137 [6.6-14.7]), and 67 mmol/mol [8.3%] (range 46-105 [6.4-11.8]) when the uveitis was quiescent, p = 0.01. Better glycaemic control was required in 10 patients during episodes of uveitis. CONCLUSIONS: Patients with DM who develop uveitis may have a high complication rate, reduced vision and poor glycaemic control. Checking blood glucose during episodes of uveitis is important. |
format | Online Article Text |
id | pubmed-3651352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36513522013-05-11 Clinical course and visual outcome in patients with diabetes mellitus and uveitis Oswal, Kadambari S Sivaraj, Ramesh R Murray, Philip I Stavrou, Panagiota BMC Res Notes Short Report PURPOSE: We report the clinical course and visual outcome of patients with diabetes mellitus (DM) who subsequently developed uveitis from any cause. METHODS: Longitudinal, retrospective case note review. RESULTS: A total of 36 patients (M/F: 18/18, 58 eyes) were included, Of the 36 patients, 35 had Type 2 DM and one had Type 1 DM. Mean age of onset of DM was 49 years and uveitis 55 years. The uveitis was bilateral in 22 (61%) patients. There were 19 patients with anterior uveitis, 12 with panuveitis and 5 with intermediate uveitis. Mean follow up was 4.4 years (range 1-18). Mean number of uveitis recurrences was 3 (range 1-7). Causes of vision of 6/18 or worse appeared related to the uveitis in 9 eyes and diabetes in 4 eyes. Cataract occurred in 22 eyes, glaucoma in 17 eyes, and cystoid macular oedema in 10 eyes. Diabetic retinopathy was detected in 38 (65.5%) eyes (29 non-proliferative including 6 with clinically significant macular oedema, and 9 proliferative). Progression of diabetic retinopathy to proliferative stage occurred in 7 eyes of 4 patients over a mean duration of 4.4 years. In 10 patients with active uveitis the mean HbA1c was 80 mmol/mol [9.5%], (range 49-137 [6.6-14.7]), and 67 mmol/mol [8.3%] (range 46-105 [6.4-11.8]) when the uveitis was quiescent, p = 0.01. Better glycaemic control was required in 10 patients during episodes of uveitis. CONCLUSIONS: Patients with DM who develop uveitis may have a high complication rate, reduced vision and poor glycaemic control. Checking blood glucose during episodes of uveitis is important. BioMed Central 2013-04-29 /pmc/articles/PMC3651352/ /pubmed/23628425 http://dx.doi.org/10.1186/1756-0500-6-167 Text en Copyright © 2013 Oswal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Oswal, Kadambari S Sivaraj, Ramesh R Murray, Philip I Stavrou, Panagiota Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title | Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title_full | Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title_fullStr | Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title_full_unstemmed | Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title_short | Clinical course and visual outcome in patients with diabetes mellitus and uveitis |
title_sort | clinical course and visual outcome in patients with diabetes mellitus and uveitis |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651352/ https://www.ncbi.nlm.nih.gov/pubmed/23628425 http://dx.doi.org/10.1186/1756-0500-6-167 |
work_keys_str_mv | AT oswalkadambaris clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis AT sivarajrameshr clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis AT murrayphilipi clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis AT stavroupanagiota clinicalcourseandvisualoutcomeinpatientswithdiabetesmellitusanduveitis |